Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of “Hold” by Analysts

Oscar Health, Inc. (NYSE:OSCR) has received an average recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $20.08.

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th.

Insider Buying and Selling

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 24.39% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Hsbc Holdings PLC boosted its holdings in shares of Oscar Health by 2.7% in the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock worth $313,000 after buying an additional 632 shares during the last quarter. Tempus Wealth Planning LLC lifted its holdings in Oscar Health by 6.7% during the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company’s stock valued at $189,000 after purchasing an additional 906 shares in the last quarter. Focus Partners Wealth lifted its holdings in Oscar Health by 1.8% during the first quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock valued at $723,000 after purchasing an additional 949 shares in the last quarter. Xponance Inc. lifted its holdings in Oscar Health by 7.1% during the first quarter. Xponance Inc. now owns 15,423 shares of the company’s stock valued at $202,000 after purchasing an additional 1,029 shares in the last quarter. Finally, CWM LLC lifted its holdings in Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after purchasing an additional 1,078 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $14.88 on Friday. The firm’s 50-day moving average price is $13.61 and its 200-day moving average price is $14.64. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.73 billion, a PE ratio of -743.38 and a beta of 1.75. Oscar Health has a 52-week low of $11.20 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business’s quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.62 EPS. As a group, analysts anticipate that Oscar Health will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.